Koers Repros Therapeutics Inc

Aandelen

26-01-18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15-12-17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12-12-17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12-12-17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12-12-17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
REPROS THERAPEUTICS INC	-.--%	+0,74%	-	-	0
LONZA GROUP AG	-0,17%	+1,47%	+3,16%	+7,43%	50,35 mld.
REVOLUTION MEDICINES, INC.	-0,47%	-3,13%	+386,19%	+590,83%	39,32 mld.
IQVIA HOLDINGS INC.	+0,93%	+2,71%	+32,75%	-5,45%	34,69 mld.
BEONE MEDICINES AG	+1,93%	+3,87%	+16,26%	+58,44%	34,08 mld.
CELLTRION, INC.	+1,68%	-1,40%	+4,23%	+27,34%	26,63 mld.
ASCENDIS PHARMA A/S	+0,07%	-4,52%	-	-	16,49 mld.
MEDPACE HOLDINGS, INC.	-0,91%	-0,23%	+69,72%	+114,56%	15,31 mld.
EUROFINS SCIENTIFIC SE	+0,43%	+3,34%	+14,96%	+17,98%	13,8 mld.
ICON PUBLIC LIMITED COMPANY	+0,65%	+2,07%	+16,01%	-31,08%	12,87 mld.
Gemiddelde	+0,39%	-0,41%	+67,91%	+97,51%	27,06 mld.
Gewogen gemiddelde per kap.	+0,47%	-0,32%	+82,05%	+122,18%